Literature DB >> 1435899

Isolation of Rochalimaea species from cutaneous and osseous lesions of bacillary angiomatosis.

J E Koehler1, F D Quinn, T G Berger, P E LeBoit, J W Tappero.   

Abstract

BACKGROUND: Bacillary angiomatosis is characterized by vascular lesions, which occur usually in patients infected with the human immunodeficiency virus (HIV). A newly described gram-negative organism, Rochalimaea henselae, has been associated with cutaneous bacillary angiomatosis, but no organism has been isolated and cultivated directly from cutaneous tissue.
METHODS: We used two methods to isolate the infecting bacterium from four HIV-infected patients with cutaneous lesions suggestive of bacillary angiomatosis: cultivation with eukaryotic tissue-culture monolayers and direct plating of homogenized tissue onto agar. The patients' blood was cultured with the lysis-centrifugation method. Isolates recovered from skin and blood were identified by sequencing all or part of the 16S ribosomal RNA gene amplified with the polymerase chain reaction.
RESULTS: R. quintana, historically known as the agent of trench fever, was isolated from cutaneous lesions in three patients, after tissue homogenates were cultivated with endothelial-cell monolayers; R. henselae was isolated from a cutaneous lesion in one patient. In two patients, R. quintana was isolated from both cutaneous tissue and blood; in one patient it was also isolated from bone.
CONCLUSIONS: In bacillary angiomatosis, either of two species of rochalimaea--R. quintana or R. henselae--can be isolated from cutaneous lesions or blood, providing an additional method of diagnosis.

Entities:  

Mesh:

Year:  1992        PMID: 1435899     DOI: 10.1056/NEJM199212033272303

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  113 in total

1.  Use of rpoB gene analysis for detection and identification of Bartonella species.

Authors:  P Renesto; J Gouvernet; M Drancourt; V Roux; D Raoult
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

Review 2.  Natural history of Bartonella infections (an exception to Koch's postulate).

Authors:  V Jacomo; P J Kelly; Didier Raoult
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

Review 3.  Current knowledge of Bartonella species.

Authors:  M Maurin; R Birtles; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-07       Impact factor: 3.267

4.  Prevalence of Bartonella species in domestic cats in The Netherlands.

Authors:  A M Bergmans; C M de Jong; G van Amerongen; C S Schot; L M Schouls
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

5.  Sequence variation in the ftsZ gene of Bartonella henselae isolates and clinical samples.

Authors:  C Ehrenborg; L Wesslén; A Jakobson; G Friman; M Holmberg
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

6.  Five-member gene family of Bartonella quintana.

Authors:  Michael F Minnick; Kate N Sappington; Laura S Smitherman; Siv G E Andersson; Olof Karlberg; James A Carroll
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

Review 7.  Recommendations for treatment of human infections caused by Bartonella species.

Authors:  J M Rolain; P Brouqui; J E Koehler; C Maguina; M J Dolan; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

8.  Diagnosis?

Authors:  M A Miller
Journal:  Can J Infect Dis       Date:  1995-05

9.  Rochalimaea elizabethae sp. nov. isolated from a patient with endocarditis.

Authors:  J S Daly; M G Worthington; D J Brenner; C W Moss; D G Hollis; R S Weyant; A G Steigerwalt; R E Weaver; M I Daneshvar; S P O'Connor
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

10.  Bartonella henselae and Bartonella quintana adherence to and entry into cultured human epithelial cells.

Authors:  H J Batterman; J A Peek; J S Loutit; S Falkow; L S Tompkins
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.